Don't know how I got wind of it but have been following ICPT for the past couple of weeks. It's now sitting at $346, down $20 on the day, not up to its usual daily performance. Last week it had a $50 upward day. If a little digestive juice medication can result in that kind of share price, I sometimes wonder what would happen to CRME on some positive news? I think this could easily be a $100 stock.
I've been around crme since '04 before the NASDAQ listing.
My memories are a bit fuzzy, but I believe they had completed the final trial and were waitng for word from the FDA (champagne on ice). The FDA gave them an 'approvable' and required one additional trial--the Act V.
Then during Act V there was a death unrelated to the treatment, and the FDA slapped the hold on them.
So I guess it's possible the FDA might approve based on real world results and not require them to re-do Act 5.